The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Structural Basis of IL-1 Family Cytokine Signaling
Open accessAbstract
Interleukin-1 (IL-1) family cytokines are key signaling molecules in both the innate and adaptive immune systems, mediating inflammation in response to a wide range of stimuli. The basic mechanism of signal initiation is a stepwise process in which an agonist cytokine binds its cognate receptor. Together, this cytokine-receptor complex recruits an often-common secondary receptor. Intracellularly, the Toll/IL-1 Receptor (TIR) domains of the two receptors are brought into close proximity, initiating an NF-κB signal transduction cascade. Due to the potent inflammatory response invoked by IL-1 family cytokines, several physiological mechanisms exist to inhibit IL-1 family signaling, including antagonist cytokines and decoy receptors. The numerous cytokines and receptors in the IL-1 superfamily are further classified into four subfamilies, dependent on their distinct cognate receptors-the IL-1, IL-33, and IL-36 subfamilies share IL-1RAcP as their secondary receptor, while IL-18 subfamily utilizes a distinct secondary receptor. Here, we describe how structural biology has informed our understanding of IL-1 family cytokine signaling, with a particular focus on molecular mechanisms of signaling complex formation and antagonism at the atomic level, as well as how these findings have advanced therapeutics to treat some chronic inflammatory diseases that are the result of dysregulated IL-1 signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
Overview of the IL ‐1 family in innate inflammation and acquired immunity
Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12621 · Cited by 1,866
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
The IL-1 family: regulators of immunity
Sims, J. E., & Smith, D. E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2691 · Cited by 1,418
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli, L. A., Sonnenberg, G. F., Abt, M. C., Alenghat, T., Ziegler, C. G. K., Doering, T. A., Angelosanto, J. M., Laidlaw, B. J., Yang, C. Y., Sathaliyawala, T., et al. (2011) · Nature Immunology · doi:10.1038/ni.2131 · Cited by 1,321
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli (2011) · PubMed · doi:10.1031/ni.2131 · Cited by 1,286
Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme
Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M. A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., et al. (1997) · Science · doi:10.1126/science.275.5297.206 · Cited by 1,155
Interleukin-33 in health and disease
Liew, F. Y., Girard, J.-P., & Turnquist, H. R. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.95 · Cited by 1,147
Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,088
A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
Salimi, M., Barlow, J. L., Saunders, S. P., Xue, L., Gutowska-Owsiak, D., Wang, X., Huang, L.-C., Johnson, D., Scanlon, S. T., McKenzie, A. N. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130351 · Cited by 979
IL-37 is a fundamental inhibitor of innate immunity
Nold, M. F., Nold-Petry, C. A., Zepp, J. A., Palmer, B. E., Bufler, P., & Dinarello, C. A. (2010) · Nature Immunology · doi:10.1038/ni.1944 · Cited by 849
Interleukin-18 Binding Protein
Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 779
Dunne, A., & O'Neill, L. A. J. (2003) · Science's STKE · doi:10.1126/stke.2003.171.re3 · Cited by 711
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Cayrol, C., & Girard, J.-P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812690106 · Cited by 707
IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy
Cayrol, C., & Girard, J.-P. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.09.004 · Cited by 699
A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.
McMahan, C. J., Slack, J. L., Mosley, B., Cosman, D., Lupton, S. D., Brunton, L. L., Grubin, C. E., Wignall, J. M., Jenkins, N. A., & Brannan, C. I. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07831.x · Cited by 677
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction
Gudbjartsson, D. F., Bjornsdottir, U. S., Halapi, E., Helgadottir, A., Sulem, P., Jonsdottir, G. M., Thorleifsson, G., Helgadottir, H., Steinthorsdottir, V., Stefansson, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.323 · Cited by 677
IL-33 is a crucial amplifier of innate rather than acquired immunity
Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A., Abe, T., Kiyonari, H., Matsumoto, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003059107 · Cited by 652
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Lefrançais, E., Roga, S., Gautier, V., Gonzalez-de-Peredo, A., Monsarrat, B., Girard, J.-P., & Cayrol, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115884109 · Cited by 594
Hoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., Weinstein, S. P., Belomestnov, P., Yancopoulos, G. D., Stahl, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23687 · Cited by 577
Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme
Afonina, I. S., Müller, C., Martin, S. J., & Beyaert, R. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.003 · Cited by 490
Purification and Characterization of the Human Interleukin-18 Receptor
Torigoe, K., Ushio, S., Okura, T., Kobayashi, S., Taniai, M., Kunikata, T., Murakami, T., Sanou, O., Kojima, H., Fujii, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25737 · Cited by 473
Nold-Petry, C. A., Lo, C. Y., Rudloff, I., Elgass, K. D., Li, S., Gantier, M. P., Lotz-Havla, A. S., Gersting, S. W., Cho, S. X., Lao, J. C., et al. (2015) · Nature Immunology · doi:10.1038/ni.3103 · Cited by 439
Sweet, R. M., Wright, H. T., Janin, J., Chothia, C. H., & Blow, D. M. (1974) · Biochemistry · doi:10.1021/bi00717a024 · Cited by 433
Towne, J. E., Garka, K. E., Renshaw, B. R., Virca, G. D., & Sims, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400117200 · Cited by 419
The family of the interleukin‐1 receptors
Boraschi, D., Italiani, P., Weil, S., & Martin, M. U. (2018) · Immunological Reviews · doi:10.1111/imr.12606 · Cited by 389
van de Veerdonk, F. L., Stoeckman, A. K., Wu, G., Boeckermann, A. N., Azam, T., Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Hao, R., Kalabokis, V., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121534109 · Cited by 380
Cytokine traps: multi-component, high-affinity blockers of cytokine action
Economides, A. N., Carpenter, L. R., Rudge, J. S., Wong, V., Koehler-Stec, E. M., Hartnett, C., Pyles, E. A., Xu, X., Daly, T. J., Young, M. R., et al. (2003) · Nature Medicine · doi:10.1038/nm811 · Cited by 359
IL-37: a new anti-inflammatory cytokine of the IL-1 family
Boraschi, D., Lucchesi, D., Hainzl, S., Leitner, M., Maier, E., Mangelberger, D., Oostingh, G. J., Pfaller, T., Pixner, C., Posselt, G., et al. (2011) · European Cytokine Network · doi:10.1684/ecn.2011.0288 · Cited by 357
Anakinra for Rheumatoid Arthritis: A Systematic Review
MERTENS, M., & SINGH, J. A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090074 · Cited by 344
Four New Members Expand the Interleukin-1 Superfamily
Smith, D. E., Renshaw, B. R., Ketchem, R. R., Kubin, M., Garka, K. E., & Sims, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1169 · Cited by 341
Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines
Henry, C. M., Sullivan, G. P., Clancy, D. M., Afonina, I. S., Kulms, D., & Martin, S. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.072 · Cited by 330
Towne, J. E., Renshaw, B. R., Douangpanya, J., Lipsky, B. P., Shen, M., Gabel, C. A., & Sims, J. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.267922 · Cited by 326
Yasuda, K., Muto, T., Kawagoe, T., Matsumoto, M., Sasaki, Y., Matsushita, K., Taki, Y., Futatsugi-Yumikura, S., Tsutsui, H., Ishii, K. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201042109 · Cited by 321
Elevated Soluble ST2 Protein Levels in Sera of Patients with Asthma with an Acute Exacerbation
OSHIKAWA, K., KUROIWA, K., TAGO, K., IWAHANA, H., YANAGISAWA, K., OHNO, S., TOMINAGA, S.-I., & SUGIYAMA, Y. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2008120 · Cited by 314
IL-36R ligands are potent regulators of dendritic and T cells
Vigne, S., Palmer, G., Lamacchia, C., Martin, P., Talabot-Ayer, D., Rodriguez, E., Ronchi, F., Sallusto, F., Dinh, H., Sims, J. E., et al. (2011) · Blood · doi:10.1182/blood-2011-05-356873 · Cited by 308
Suppression of inflammation and acquired immunity by IL‐37
Cavalli, G., & Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12605 · Cited by 291
Debets, R., Timans, J. C., Homey, B., Zurawski, S., Sana, T. R., Lo, S., Wagner, J., Edwards, G., Clifford, T., Menon, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1440 · Cited by 286
Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1β
Vigers, G. P. A., Anderson, L. J., Caffes, P., & Brandhuber, B. J. (1997) · Nature · doi:10.1038/386190a0 · Cited by 276
IL‐1: Discoveries, controversies and future directions
Dinarello, C. A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040319 · Cited by 268
Revised Nomenclature for Antigen-Nonspecific T Cell Proliferation and Helper Factors
(1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.6.2928 · Cited by 255
Schreuder, H., Tardif, C., Trump-Kallmeyer, S., Soffientini, A., Sarubbi, E., Akeson, A., Bowlin, T., Yanofsky, S., & Barrett, R. W. (1997) · Nature · doi:10.1038/386194a0 · Cited by 247
Cohen, S. B., Proudman, S., Kivitz, A. J., Burch, F. X., Donohue, J. P., Burstein, D., Sun, Y.-N., Banfield, C., Vincent, M. S., Ni, L., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3430 · Cited by 246
Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factors
Mizel, S. B., & Farrar, J. J. (1979) · Cellular Immunology · doi:10.1016/0008-8749(79)90139-4 · Cited by 234
Annotating genes with potential roles in the immune system: six new members of the IL-1 family
Dunn, E., Sims, J. E., Nicklin, M. J. H., & O'Neill, L. A. J. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02034-8 · Cited by 233
Vigne, S., Palmer, G., Martin, P., Lamacchia, C., Strebel, D., Rodriguez, E., Olleros, M. L., Vesin, D., Garcia, I., Ronchi, F., et al. (2012) · Blood · doi:10.1182/blood-2012-06-439026 · Cited by 218
Cloning and Characterization of IL-1HY2, a Novel Interleukin-1 Family Member
Lin, H., Ho, A. S., Haley-Vicente, D., Zhang, J., Bernal-Fussell, J., Pace, A. M., Hansen, D., Schweighofer, K., Mize, N. K., & Ford, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010095200 · Cited by 218
Structural insights into the interaction of IL-33 with its receptors
Liu, X., Hammel, M., He, Y., Tainer, J. A., Jeng, U.-S., Zhang, L., Wang, S., & Wang, X. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308651110 · Cited by 213
Lingel, A., Weiss, T. M., Niebuhr, M., Pan, B., Appleton, B. A., Wiesmann, C., Bazan, J. F., & Fairbrother, W. J. (2009) · Structure · doi:10.1016/j.str.2009.08.009 · Cited by 212
IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms
Hung, L.-Y., Lewkowich, I. P., Dawson, L. A., Downey, J., Yang, Y., Smith, D. E., & Herbert, D. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206587110 · Cited by 206
Hong, D. S., Hui, D., Bruera, E., Janku, F., Naing, A., Falchook, G. S., Piha-Paul, S., Wheler, J. J., Fu, S., Tsimberidou, A. M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70155-x · Cited by 199
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma
Brunner, M., Krenn, C., Roth, G., Moser, B., Dworschak, M., Jensen-Jarolim, E., Spittler, A., Sautner, T., Bonaros, N., Wolner, E., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2184-x · Cited by 182
Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses
Mora, J., Schlemmer, A., Wittig, I., Richter, F., Putyrski, M., Frank, A.-C., Han, Y., Jung, M., Ernst, A., Weigert, A., et al. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw006 · Cited by 180
Purification and characterization of a novel soluble receptor for interleukin 1.
Symons, J. A., Eastgate, J. A., & Duff, G. W. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1251 · Cited by 171
The Increase in Serum Soluble ST2 Protein Upon Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Tajima, S., Oshikawa, K., Tominaga, S.-I., & Sugiyama, Y. (2003) · Chest · doi:10.1378/chest.124.4.1206 · Cited by 169
Yoshida, T., Yasumura, M., Uemura, T., Lee, S.-J., Ra, M., Taguchi, R., Iwakura, Y., & Mishina, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2136-11.2011 · Cited by 166
Structural insights into the assembly and activation of IL-1β with its receptors
Wang, D., Zhang, S., Li, L., Liu, X., Mei, K., & Wang, X. (2010) · Nature Immunology · doi:10.1038/ni.1925 · Cited by 162
Crystal structure of the cytokine interleukin‐1 beta.
Priestle, J. P., Schär, H., & Grütter, M. G. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02818.x · Cited by 152
Structure of interleukin 1 .alpha. at 2.7-.ANG. resolution
Graves, B. J., Hatada, M. H., Hendrickson, W. A., Miller, J. K., Madison, V., & Satow, Y. (1990) · Biochemistry · doi:10.1021/bi00463a009 · Cited by 152
The structural basis for receptor recognition of human interleukin-18
Tsutsumi, N., Kimura, T., Arita, K., Ariyoshi, M., Ohnishi, H., Yamamoto, T. S., Zuo, X., Maenaka, K., Park, E. Y., Kondo, N., et al. (2014) · Nature Communications · doi:10.1038/ncomms6340 · Cited by 149
Identification of Human ST2 Protein in the Sera of Patients with Autoimmune Diseases
Kuroiwa, K., Arai, T., Okazaki, H., Minota, S., & Tominaga, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5090 · Cited by 144
Smith, D. E., Lipsky, B. P., Russell, C. B., Ketchem, R. R., Kirchner, J., Hensley, K. M., Huang, Y., Friedman, W., Boissonneault, V., Plante, M.-M., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.020 · Cited by 137
Louten, J., Rankin, A. L., Li, Y., Murphy, E. E., Beaumont, M., Moon, C., Bourne, P. A., McClanahan, T. K., Pflanz, S., & Malefyt, R. D. W. (2011) · International Immunology · doi:10.1093/intimm/dxr006 · Cited by 136
Structure of the activating IL-1 receptor signaling complex
Thomas, C., Bazán, J. F., & García, K. C. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2260 · Cited by 135
The structure and binding mode of interleukin-18
Kato, Z., Jee, J., Shikano, H., Mishima, M., Ohki, I., Ohnishi, H., Li, A., Hashimoto, K., Matsukuma, E., Omoya, K., et al. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb993 · Cited by 135
Yoshida, T., Shiroshima, T., Lee, S.-J., Yasumura, M., Uemura, T., Chen, X., Iwakura, Y., & Mishina, M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4637-11.2012 · Cited by 134
Crystal Structure of the Toll/Interleukin-1 Receptor Domain of Human IL-1RAPL
Khan, J., Brint, E. K., O'Neill, L. A. J., & Tong, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403434200 · Cited by 132
Rudloff, I., Godsell, J. D., Nold‐Petry, C. A., Harris, J., Hoi, A. Y.-B., Morand, E. F., & Nold, M. F. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39328 · Cited by 117
Evans, R. J., Bray, J., Childs, J. D., Vigers, G. P. A., Brandhuber, B. J., Skalicky, J. J., Thompson, R. C., & Eisenberg, S. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11477 · Cited by 110
Yanofsky, S. D., Baldwin, D. N., Butler, J. H., Holden, F., Jacobs, J. W., Balasubramanian, P., Chinn, J. P., Cwirla, S. E., Peters-Bhatt, E., Whitehorn, E. A., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7381 · Cited by 110
Biology of IL ‐38 and its role in disease
van de Veerdonk, F. L., de Graaf, D. M., Joosten, L. A. B., & Dinarello, C. A. (2017) · Immunological Reviews · doi:10.1111/imr.12612 · Cited by 98
Molecular Determinants of Agonist and Antagonist Signaling through the IL-36 Receptor
Günther, S., & Sundberg, E. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400538 · Cited by 84
Self-citationModel of interaction of the IL‐1 receptor accessory protein IL‐1RAcP with the IL‐1β/IL‐1RI complex
Casadio, R., Frigimelica, E., Bossù, P., Neumann, D., Martin, M. U., Tagliabue, A., & Boraschi, D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02515-7 · Cited by 82
Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein
Krumm, B., Meng, X., Li, Y., Xiang, Y., & Deng, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809086106 · Cited by 81
Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL1R-rp2)
Lovenberg, T. W., Crowe, P. D., Liu, C., Chalmers, D. T., Liu, X.-J., Liaw, C. W., Clevenger, W., Oltersdorf, T., Souza, E. B. D., & Maki, R. A. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00047-1 · Cited by 77
IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor
Günther, S., Deredge, D. J., Bowers, A. L., Luchini, A., Bonsor, D. A., Beadenkopf, R., Liotta, L. A., Wintrode, P. L., & Sundberg, E. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.004 · Cited by 73
Self-citationHomodimerization attenuates the anti-inflammatory activity of interleukin-37
Ellisdon, A. M., Nold‐Petry, C. A., D’Andrea, L., Cho, S., Lao, J. C., Rudloff, I., Ngo, D., Lo, C. Y.-W., da Costa, T. P. S., Perugini, M. A., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aaj1548 · Cited by 72
Ren, X., Gelinas, A. D., von Carlowitz, I., Janjić, N., & Pyle, A. M. (2017) · Nature Communications · doi:10.1038/s41467-017-00864-2 · Cited by 72
X-ray structure of interleukin-1 receptor antagonist at 2.0-A resolution.
Vigers, G. P. A., Caffes, P. L., Evans, R. J., Thompson, R. C., Eisenberg, S. P., & Brandhuber, B. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99957-6 · Cited by 70
Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.
Ju, G., Labriola–Tompkins, E., Campen, C. A., Benjamin, W. R., Karas, J. L., Plocinski, J. M., Biondi, D., Kaffka, K. L., Kilian, P. L., & Eisenberg, S. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2658 · Cited by 69
Yamagata, A., Yoshida, T., Sato, Y., Goto‐Ito, S., Uemura, T., Maeda, A., Shiroshima, T., Iwasawa-Okamoto, S., Mori, H., Mishina, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7926 · Cited by 67
X-ray Crystal Structure of a Small Antagonist Peptide Bound to Interleukin-1 Receptor Type 1
Vigers, G. P. A., Dripps, D. J., Edwards, C. K., & Brandhuber, B. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006071200 · Cited by 60
Design of a superior cytokine antagonist for topical ophthalmic use
Hou, J., Townson, S. A., Kovalchin, J., Masci, A., Kiner, O., Shu, Y., King, B. M., Schirmer, E. B., Golden, K., Thomas, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217996110 · Cited by 58
Yang, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118671 · Cited by 42
Dunn, E., Gay, N. J., Bristow, A. F., Gearing, D. P., O'Neill, L. A. J., & Pei, X. Y. (2003) · Biochemistry · doi:10.1021/bi0341197 · Cited by 40
Structural basis for the specific recognition of IL‐18 by its alpha receptor
Wei, H., Wang, D., Qian, Y., Liu, X., Fan, S., Yin, H.-S., & Wang, X. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.09.019 · Cited by 33
Simoncsits, A., Bristulf, J., Tjörnhammar, M. L., Cserző, M., Pongor, S., Георгиевна, Р. Е., Gatti, S., & Bartfai, T. (1994) · Cytokine · doi:10.1016/1043-4666(94)90043-4 · Cited by 22
Structure and function of interleukin-1, based on crystallographic and modeling studies
Veerapandian, B. (1992) · Biophysical Journal · doi:10.1016/s0006-3495(92)81796-4 · Cited by 19
Conformational Sampling and Binding Site Assessment of Suppression of Tumorigenicity 2 Ectodomain
Yang, C., Delproposto, J., Chinnaswamy, K., Brown, W. C., Wang, S., Stuckey, J. A., & Wang, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146522 · Cited by 13
Cited by
Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis
Molnar, V., Matišić, V., Kodvanj, I., Bjelica, R., Jeleč, Ž., Hudetz, D., Rod, E., Čukelj, F., Vrdoljak, T., Vidović, D., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179208 · Cited by 615
Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review
Al-Qahtani, A. A., Alhamlan, F. S., & Al-Qahtani, A. A. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9010013 · Cited by 291
Harrell, C. R., Markovic, B. S., Fellabaum, C., Arsenijevic, N., Djonov, V., & Volarevic, V. (2020) · BioFactors · doi:10.1002/biof.1587 · Cited by 106
Innate immune sensing of adeno-associated virus vectors
Cao, D., Byrne, B. J., de Jong, Y. P., Terhorst, C., Duan, D., Herzog, R. W., & Kumar, S. R. P. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.040 · Cited by 50
Il-1r1 drives leukemogenesis induced by Tet2 loss
Burns, S. S., Kumar, R., Pasupuleti, S. K., So, K., Zhang, C., & Kapur, R. (2022) · Leukemia · doi:10.1038/s41375-022-01665-3 · Cited by 32
Metadata
- Authors
- Fields, J. K., Günther, S., & Sundberg, E. J.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-06-20
- Volume
- 10
- Pages
- 1412-1412
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2952643930
- Cited by
- 299
- References
- 93
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.